Your browser doesn't support javascript.
loading
FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA.
Deng, Minhua; Wang, Ning; Li, Zhiyong; Chen, Rixin; Duan, Jinling; Peng, Yulu; Wu, Zeshen; Zhang, Zhiling; Jiang, Lijuan; Zheng, Xianchong; Xie, Dan; Wei, Wensu; Liu, Zhuowei; Zhou, Fangjian.
Affiliation
  • Deng M; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Wang N; Department of Urology, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Li Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Chen R; Department of Urology, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Duan J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Peng Y; Department of Urology, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Wu Z; Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhang Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Jiang L; Department of Pathology, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Zheng X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Xie D; Department of Urology, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Wei W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Liu Z; Department of Urology, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
  • Zhou F; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
Cell Death Dis ; 13(2): 170, 2022 02 22.
Article de En | MEDLINE | ID: mdl-35194031

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la vessie urinaire / Carcinome transitionnel / Protéines de liaison à l'ARN / Facteur-1 associé aux récepteurs de TNF Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Cell Death Dis Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la vessie urinaire / Carcinome transitionnel / Protéines de liaison à l'ARN / Facteur-1 associé aux récepteurs de TNF Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Cell Death Dis Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni